We are live on ! Find out more
ARKG icon

ARK Genomic Revolution ETF
ARKG

168 hedge funds and large institutions have $483M invested in ARK Genomic Revolution ETF in 2020 Q2 according to their latest regulatory filings, with 78 funds opening new positions, 55 increasing their positions, 14 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

600% more funds holding in top 10

Funds holding in top 10: 1 → 7 (+6)

420% more first-time investments, than exits

New positions opened: 78 | Existing positions closed: 15

293% more repeat investments, than reductions

Existing positions increased: 55 | Existing positions reduced: 14

179% more capital invested

Capital invested by funds: $173M → $483M (+$310M)

58% more funds holding

Funds holding: 106 → 168 (+62)

2.93% more ownership

Funds ownership: 33.51% → 36.44% (+2.9%)

Holders
168
Holders Change
+62
Holders Change %
+58.49%
% of All Funds
3.44%
Holding in Top 10
7
Holding in Top 10 Change
+6
Holding in Top 10 Change %
+600%
% of All Funds
0.14%
New
78
Increased
55
Reduced
14
Closed
15
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
MCM
Mainstay Capital Management
Michigan
+$16.9M
2
UBS Group
UBS Group
Switzerland
+$15.8M
3
Morgan Stanley
Morgan Stanley
New York
+$14.9M
4
LFA
Legend Financial Advisors
Pennsylvania
+$10.1M
5
AWM
AE Wealth Management
Kansas
+$8.67M

Top Sellers

Rank Fund Capital Flow
1
Financial Engines Advisors
Financial Engines Advisors
California
-$1.57M
2
Mercer Global Advisors
Mercer Global Advisors
Colorado
-$1.26M
3
CWM
Concentrum Wealth Management
California
-$1.23M
4
Jane Street
Jane Street
New York
-$950K
5
KA
Kovack Advisors
Florida
-$835K
Name Holding Trade Value Shares
Change 		Change in
Stake
XF
101
XML Financial
Maryland
$322K +$265K +6,169 New
IFG
102
Independent Financial Group
California
$321K +$264K +6,159 New
LA
103
LVW Advisors
New York
$302K +$248K +5,790 New
EH
104
Equitable Holdings
New York
$291K +$239K +5,571 New
EPA
105
Element Pointe Advisors
Florida
$278K +$229K +5,344 New
CG
106
Caprock Group
Idaho
$272K -$176K -4,107 -44%
CAM
107
Cresset Asset Management
Illinois
$265K +$218K +5,089 New
KA
108
Kovack Advisors
Florida
$258K -$835K -19,461 -80%
SG
109
StoneX Group
New York
$256K +$211K +4,917 New
GIA
110
Gladstone Institutional Advisory
Florida
$253K -$167K -3,891 -44%
Truist Financial
111
Truist Financial
North Carolina
$253K +$208K +4,859 New
V
112
Veritable
Delaware
$249K +$205K +4,777 New
WIA
113
World Investment Advisors
California
$246K +$182K +4,246 New
SHWM
114
Silicon Hills Wealth Management
Texas
$229K +$188K +4,385 New
FFS
115
Founders Financial Securities
Maryland
$227K +$186K +4,348 New
ACA
116
Ascension Capital Advisors
Texas
$227K +$187K +4,354 New
NA
117
NewEdge Advisors
Louisiana
$226K +$186K +4,331 New
FFN
118
Focus Financial Network
Minnesota
$223K +$184K +4,282 New
CWM
119
Cabot Wealth Management
Massachusetts
$223K +$184K +4,293 New
CA
120
Cetera Advisors
Colorado
$221K +$181K +4,230 New
IA
121
IFP Advisors
Florida
$219K +$68.8K +1,604 +60%
ECM
122
ExodusPoint Capital Management
New York
$219K +$180K +4,200 New
CAC
123
Certified Advisory Corp
Florida
$218K +$17.2K +400 +11%
PWP
124
Principle Wealth Partners
Connecticut
$211K +$174K +4,052 New
MFGP
125
Marshall Financial Group (Pennsylvania)
Pennsylvania
$209K +$172K +4,000 New
3 4
5
6 7

ARKG Hedge Fund Activity: Q2 2020 in Review

168 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in ARK Genomic Revolution ETF (ARKG) for Q2 2020, worth a combined $483M — up 179% from $173M a quarter earlier.

Buyers outnumbered sellers: 78 funds opened new ARKG positions and 15 closed out — a net gain of 63 holders — while 55 added to existing stakes and 14 trimmed.

The largest buyer was Mainstay Capital Management, adding an estimated $16.9M. The largest seller was Financial Engines Advisors, exiting entirely with an estimated $1.57M sold.

  • 168 institutional investors held ARK Genomic Revolution ETF (ARKG) as of Q2 2020, up from 106 in Q1 2020.
  • Funds reported $483M of ARK Genomic Revolution ETF stock for Q2 2020, up 179% quarter-over-quarter.
  • 78 funds opened new ARK Genomic Revolution ETF positions in Q2 2020 and 15 closed out, a net change of +63 holders.
  • The largest ARK Genomic Revolution ETF buyer in Q2 2020 was Mainstay Capital Management, an estimated $16.9M added.
  • The largest ARK Genomic Revolution ETF seller in Q2 2020 was Financial Engines Advisors, an estimated $1.57M sold.

Based on aggregated 13F filings for Q2 2020.